{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:19:15Z","timestamp":1792750755424,"version":"4.5.0"},"reference-count":387,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2020M3E5D9080660"],"award-info":[{"award-number":["2020M3E5D9080660"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.arr.2021.101451","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T02:36:29Z","timestamp":1629858989000},"page":"101451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: Insights and therapeutic approaches from periphery"],"prefix":"10.1016","volume":"71","author":[{"given":"Rahat","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6706-199X","authenticated-orcid":false,"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4317-1072","authenticated-orcid":false,"given":"Myeong Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2021.101451_bib0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/1947-2714.159325","article-title":"Association between periodontitis and Alzheimer\u2019s disease","volume":"7","author":"Abbayya","year":"2015","journal-title":"N. Am. J. Med. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib0015","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuint.2007.12.002","article-title":"ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-\u03b2 peptide (1\u201340) at the blood\u2013brain barrier","volume":"52","author":"Akanuma","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2021.101451_bib0020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuint.2007.12.002","article-title":"ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-beta peptide (1-40) at the blood-brain barrier","volume":"52","author":"Akanuma","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2021.101451_bib0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","article-title":"Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer\u2019s disease: a randomized, double-blind and controlled trial","volume":"8","author":"Akbari","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib0030","doi-asserted-by":"crossref","first-page":"30406","DOI":"10.1074\/jbc.M414686200","article-title":"Expression of scavenger receptors in glial cells: comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound \u03b2-amyloid","volume":"280","author":"Alarc\u00f3n","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/npp.2008.172","article-title":"Target identification for CNS diseases by transcriptional profiling","volume":"34","author":"Altar","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2021.101451_bib0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp-2020-323603","article-title":"Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer\u2019s disease: an observational clinical study","volume":"91","author":"Amin","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.arr.2021.101451_bib0045","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1111\/j.1532-5415.2008.01934.x","article-title":"Cognitive effects of treating obstructive sleep apnea in Alzheimer\u2019s disease: a randomized controlled study","volume":"56","author":"Ancoli\u2010Israel","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.arr.2021.101451_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00401-011-0892-1","article-title":"Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer\u2019s disease and apoE TR mouse cortex","volume":"123","author":"Arold","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2021.101451_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","article-title":"Serum creatinine levels correlate with plasma amyloid \u03b2 protein","volume":"16","author":"Arvanitakis","year":"2002","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2021.101451_bib0060","article-title":"\u03b2-amyloid: the known unknowns","author":"Ayton","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2021.101451_bib0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cne.21974","article-title":"Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled\u2010up primate brain","volume":"513","author":"Azevedo","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib0070","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1523\/JNEUROSCI.16-24-07910.1996","article-title":"Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-\u03b2 peptide (1\u201340)","volume":"16","author":"Backstrom","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/85525","article-title":"Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy","volume":"7","author":"Bacskai","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnana.2017.00101","article-title":"The paravascular pathway for brain waste clearance: current understanding, significance and controversy","volume":"11","author":"Bacyinski","year":"2017","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.arr.2021.101451_bib0085","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid \u03b2-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.25100\/cm.v47i4.2640","article-title":"Amyloid-beta immunotherapy: the hope for Alzheimer disease?","volume":"47","author":"Barrera-Ocampo","year":"2016","journal-title":"Colomb. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0100","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2967\/jnumed.116.185017","article-title":"Clinical use and utility of amyloid imaging","volume":"58","author":"Barthel","year":"2017","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0105","first-page":"217","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","author":"Barthelemy","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2021.101451_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nm.4022","article-title":"PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease","volume":"22","author":"Baruch","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0120","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-\u03b2 synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12974-020-01750-3","article-title":"A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer\u2019s disease","volume":"17","author":"Bawa","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.arr.2021.101451_bib0130","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid \u03b2-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.arr.2021.101451_bib0135","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1517\/13543784.2014.905542","article-title":"Investigational drugs in Alzheimer\u2019s disease: current progress","volume":"23","author":"Berk","year":"2014","journal-title":"Expert opinion on investigational drugs"},{"key":"10.1016\/j.arr.2021.101451_bib0140","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-161192","article-title":"The link between type 2 diabetes and neurodegeneration: roles for amyloid-\u03b2, amylin, and tau proteins","volume":"59","author":"Bharadwaj","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.arr.2021.101451_bib0145","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arr.2021.101451_bib0150","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid \u03b2-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"Biere","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0155","article-title":"Increased risk of Alzheimer\u2019s disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","author":"Biessels","year":"2005","journal-title":"Portland Press Limited."},{"key":"10.1016\/j.arr.2021.101451_bib0160","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.arr.2021.101451_bib0165","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1358\/dnp.2009.22.6.1395256","article-title":"Amyloid-targeted therapeutics in Alzheimer\u2019s disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization","volume":"22","author":"Boada","year":"2009","journal-title":"Drug news & perspectives"},{"key":"10.1016\/j.arr.2021.101451_bib0170","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.1995.tb07001.x","article-title":"Neuropsychological function in patients with end\u2010stage heart failure before and after cardiac transplantation","volume":"91","author":"Bornstein","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.arr.2021.101451_bib0175","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: altered monocyte function and amyloid biology","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0180","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1021\/nn300489k","article-title":"PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer\u2019s disease","volume":"6","author":"Brambilla","year":"2012","journal-title":"ACS nano"},{"key":"10.1016\/j.arr.2021.101451_bib0185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuroscience.2008.07.042","article-title":"Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells","volume":"156","author":"Brandenburg","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0190","doi-asserted-by":"crossref","first-page":"16941","DOI":"10.1074\/jbc.M000937200","article-title":"Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer\u2019s disease amyloid fibrils by microglia","volume":"275","author":"Brazil","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arr.2021.101451_bib0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0074-7742(07)82011-3","article-title":"Systemic and acquired immune responses in Alzheimer\u2019s disease","volume":"82","author":"Britschgi","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.arr.2021.101451_bib0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and passive immunotherapy for neurodegenerative disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.arr.2021.101451_bib0205","series-title":"One Target, One Treatment? Not for Alzheimer\u2019s Disease","author":"Brooks","year":"2015"},{"key":"10.1016\/j.arr.2021.101451_bib0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12640-015-9552-x","article-title":"Serum amyloid-beta levels are increased in patients with chronic obstructive pulmonary disease","volume":"28","author":"Bu","year":"2015","journal-title":"Neurotoxicity research"},{"key":"10.1016\/j.arr.2021.101451_bib0215","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ene.12477","article-title":"A study on the association between infectious burden and A lzheimer\u2019s disease","volume":"22","author":"Bu","year":"2015","journal-title":"European journal of neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0220","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/mp.2017.204","article-title":"Blood-derived amyloid-\u03b2 protein induces Alzheimer\u2019s disease pathologies","volume":"23","author":"Bu","year":"2018","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MNM.0000000000000633","article-title":"Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol \u03b2-amyloid PET brain images","volume":"38","author":"Buckley","year":"2017","journal-title":"Nuclear medicine communications"},{"key":"10.1016\/j.arr.2021.101451_bib0230","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1681\/ASN.2012050536","article-title":"Cognitive disorders and dementia in CKD: the neglected kidney-brain axis","volume":"24","author":"Bugnicourt","year":"2013","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.arr.2021.101451_bib0235","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0021-9258(18)48529-8","article-title":"Assembly and aggregation properties of synthetic Alzheimer\u2019s A4\/beta amyloid peptide analogs","volume":"267","author":"Burdick","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0240","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1523\/JNEUROSCI.23-13-05645.2003","article-title":"Presenilin redistribution associated with aberrant cholesterol transport enhances \u03b2-amyloid production in vivo","volume":"23","author":"Burns","year":"2003","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-018-0511-7","article-title":"Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)","volume":"6","author":"Burwinkel","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.arr.2021.101451_bib0250","doi-asserted-by":"crossref","first-page":"15977","DOI":"10.1016\/S0021-9258(18)55493-4","article-title":"The amyloid precursor protein of Alzheimer\u2019s disease is released by human platelets","volume":"265","author":"Bush","year":"1990","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0255","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3233\/JAD-180098","article-title":"Role of blood-brain barrier in alzheimer\u2019s disease","volume":"63","author":"Cai","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arr.2021.101451_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-1-48","article-title":"Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer\u2019s disease","volume":"1","author":"Carare","year":"2013","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.arr.2021.101451_bib0265","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nano.2017.12.006","article-title":"Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer\u2019s disease-like transgenic mouse model","volume":"14","author":"Carradori","year":"2018","journal-title":"Nanomedicine : nanotechnology, biology, and medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0270","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-7-6","article-title":"Serum levels of S100B and NSE proteins in Alzheimer\u2019s disease patients","volume":"7","author":"Chaves","year":"2010","journal-title":"Journal of neuroinflammation"},{"key":"10.1016\/j.arr.2021.101451_bib0275","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/bbrc.1995.2103","article-title":"Platelets are the primary source of amyloid \u03b2-peptide in human blood","volume":"213","author":"Chen","year":"1995","journal-title":"Biochemical and biophysical research communications"},{"key":"10.1016\/j.arr.2021.101451_bib0280","first-page":"96","article-title":"Altered peripheral profile of blood cells in Alzheimer disease: a hospital-based case-control study","author":"Chen","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0285","doi-asserted-by":"crossref","first-page":"23528","DOI":"10.1002\/jcp.28921","article-title":"Abnormal platelet amyloid-\u03b2 precursor protein metabolism in SAMP8 mice: evidence for peripheral marker in Alzheimer\u2019s disease","volume":"234","author":"Chen","year":"2019","journal-title":"Journal of cellular physiology"},{"key":"10.1016\/j.arr.2021.101451_bib0290","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41398-020-01113-9","article-title":"Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer\u2019s disease","volume":"10","author":"Chen","year":"2020","journal-title":"Translational psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib0295","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1766822","article-title":"Small RNA fingerprinting of Alzheimer\u2019s disease frontal cortex extracellular vesicles and their comparison with peripheral extracellular vesicles","volume":"9","author":"Cheng","year":"2020","journal-title":"Journal of extracellular vesicles"},{"key":"10.1016\/j.arr.2021.101451_bib0300","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer\u2019s disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arr.2021.101451_bib0305","doi-asserted-by":"crossref","first-page":"11993","DOI":"10.1073\/pnas.91.25.11993","article-title":"Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation","volume":"91","author":"Citron","year":"1994","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.arr.2021.101451_bib0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0047-6374(91)90081-A","article-title":"Altered membrane anisotropy gradients of plasma membranes of living peripheral blood leukocytes in aging and Alzheimer\u2019s disease","volume":"59","author":"Collins","year":"1991","journal-title":"Mechanisms of ageing and development"},{"key":"10.1016\/j.arr.2021.101451_bib0315","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"Collins","year":"2012","journal-title":"Nature Reviews Microbiology"},{"key":"10.1016\/j.arr.2021.101451_bib0320","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1021\/acschemneuro.0c00426","article-title":"Coevolution of atomic resolution and whole-brain imaging for tau neurofibrillary tangles","volume":"11","author":"Dalton","year":"2020","journal-title":"ACS chemical neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0325","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1523\/JNEUROSCI.23-24-08532.2003","article-title":"Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-\/- knock-out mice","volume":"23","author":"Das","year":"2003","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0330","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/1381612043384844","article-title":"ABC transporters and the blood-brain barrier","volume":"10","author":"David","year":"2004","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.arr.2021.101451_bib0335","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-\u03b2 peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nature medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0340","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.arr.2021.101451_bib0345","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuron.2004.07.017","article-title":"LRP\/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms","volume":"43","author":"Deane","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib0350","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","article-title":"A multimodal RAGE-specific inhibitor reduces amyloid \u03b2\u2013mediated brain disorder in a mouse model of Alzheimer disease","volume":"122","author":"Deane","year":"2012","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.arr.2021.101451_bib0355","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1212\/WNL.0000000000003482","article-title":"Dementia risk in renal dysfunction: a systematic review and meta-analysis of prospective studies","volume":"88","author":"Deckers","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0360","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.neurobiolaging.2012.12.004","article-title":"Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes","volume":"34","author":"Delvaux","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arr.2021.101451_bib0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neurobiolaging.2017.05.012","article-title":"Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer\u2019s, Parkinson\u2019s, control, and those at risk for developing Alzheimer\u2019s","volume":"58","author":"Delvaux","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arr.2021.101451_bib0370","first-page":"51","article-title":"Detection of Alzheimer\u2019s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers","volume":"3","author":"DeMarshall","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.arr.2021.101451_bib0375","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.arr.2021.101451_bib0380","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","article-title":"Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"295","author":"DeMattos","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib0385","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1126\/science.1067568","article-title":"Brain to plasma amyloid-\u03b2 efflux: a measure of brain amyloid burden in a mouse model of Alzheimer\u2019s disease","volume":"295","author":"DeMattos","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib0390","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archneur.1996.00550110114019","article-title":"Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome","volume":"53","author":"Di Luca","year":"1996","journal-title":"Archives of neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0395","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1084\/jem.20182386","article-title":"Sex-specific effects of microbiome perturbations on cerebral Abeta amyloidosis and microglia phenotypes","volume":"216","author":"Dodiya","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.arr.2021.101451_bib0400","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","article-title":"Blood-based protein biomarkers for diagnosis of Alzheimer disease","volume":"69","author":"Doecke","year":"2012","journal-title":"Archives of neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0405","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","article-title":"RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease","volume":"112","author":"Donahue","year":"2006","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib0410","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1997.69010299.x","article-title":"\u03b12\u2010Macroglobulin as a \u03b2\u2010Amyloid Peptide\u2010Binding Plasma Protein","volume":"69","author":"Du","year":"1997","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0415","doi-asserted-by":"crossref","first-page":"24540","DOI":"10.1074\/jbc.M007579200","article-title":"Degradation of the Alzheimer\u2019s amyloid \u03b2 peptide by endothelin-converting enzyme","volume":"276","author":"Eckman","year":"2001","journal-title":"Journal of Biological chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0420","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied A\u03b2-containing inoculates induce cerebral \u03b2-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib0425","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1523\/JNEUROSCI.1608-14.2014","article-title":"Multiple factors contribute to the peripheral induction of cerebral \u03b2-amyloidosis","volume":"34","author":"Eisele","year":"2014","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0430","first-page":"4","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease","author":"ElAli","year":"2013","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.arr.2021.101451_bib0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphys.2013.00045","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease","volume":"4","author":"ElAli","year":"2013","journal-title":"Frontiers in physiology"},{"key":"10.1016\/j.arr.2021.101451_bib0440","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.neurobiolaging.2007.02.016","article-title":"Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia","volume":"29","author":"Engelborghs","year":"2008","journal-title":"Neurobiology of aging"},{"key":"10.1016\/j.arr.2021.101451_bib0445","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/j.arr.2021.101451_bib0450","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnagi.2019.00174","article-title":"Liver dysfunction as a novel player in Alzheimer\u2019s progression: looking outside the brain","volume":"11","author":"Estrada","year":"2019","journal-title":"Frontiers in aging neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0455","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer\u2019s disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.arr.2021.101451_bib0460","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1007\/s12035-018-0868-4","article-title":"Peripheral and central effects of memantine in a mixed preclinical mice model of obesity and familial alzheimer\u2019s disease","volume":"55","author":"Ettcheto","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.arr.2021.101451_bib0465","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jnr.10745","article-title":"Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets","volume":"74","author":"Evin","year":"2003","journal-title":"Journal of neuroscience research"},{"key":"10.1016\/j.arr.2021.101451_bib0470","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1097\/00001756-200109170-00042","article-title":"Plasmin cleaves A\u03b242 in vitro and prevents its aggregation into \u03b2-pleated sheet structures","volume":"12","author":"Exley","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.arr.2021.101451_bib0475","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.081620098","article-title":"Simvastatin strongly reduces levels of Alzheimer\u2019s disease \u03b2-amyloid peptides A\u03b242 and A\u03b240 in vitro and in vivo","volume":"98","author":"Fassbender","year":"2001","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.arr.2021.101451_bib0480","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00314454","article-title":"Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease","volume":"236","author":"Ferreiro","year":"1989","journal-title":"Journal of neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0485","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s11064-007-9349-2","article-title":"Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes","volume":"32","author":"Fisk","year":"2007","journal-title":"Neurochemical research"},{"key":"10.1016\/j.arr.2021.101451_bib0490","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0495","doi-asserted-by":"crossref","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","article-title":"Abca1 deficiency affects alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-Targeted replacement mice","volume":"32","author":"Fitz","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0500","first-page":"7","article-title":"The role of astrocytes in amyloid production and Alzheimer\u2019s disease","author":"Frost","year":"2017","journal-title":"Open Biol"},{"key":"10.1016\/j.arr.2021.101451_bib0505","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends in immunology"},{"key":"10.1016\/j.arr.2021.101451_bib0510","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-191320","article-title":"Relationship between peripheral transport proteins and plasma Amyloid-\u03b2 in patients with alzheimer\u2019s disease were different from cognitively normal controls: a propensity score matching analysis","volume":"78","author":"Gao","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arr.2021.101451_bib0515","series-title":"Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease","first-page":"357","article-title":"Microbiota-gut-brain axis and cognitive function","author":"Gareau","year":"2014"},{"key":"10.1016\/j.arr.2021.101451_bib0520","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of \u03b2-amyloid precursor protein trafficking by insulin reduces intraneuronal \u03b2-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0525","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid\u2010borne amyloid \u03b2\u2010peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi\u2010Egea","year":"1996","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0530","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(97)00400-6","article-title":"Alzheimer\u2019s soluble amyloid \u03b2 is a normal component of human urine","volume":"408","author":"Ghiso","year":"1997","journal-title":"FEBS letters"},{"key":"10.1016\/j.arr.2021.101451_bib0535","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42","volume":"279","author":"Ghiso","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arr.2021.101451_bib0540","doi-asserted-by":"crossref","first-page":"45897","DOI":"10.1074\/jbc.M407668200","article-title":"Systemic catabolism of Alzheimer\u2019s A\u03b240 and A\u03b242","volume":"279","author":"Ghiso","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0545","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0896-6273(90)90100-T","article-title":"Expression of \u03b2 amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer\u2019s disease using PCR","volume":"4","author":"Golde","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib0550","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn.2432","article-title":"Formation and maintenance of Alzheimer\u2019s disease \u03b2-amyloid plaques in the absence of microglia","volume":"12","author":"Grathwohl","year":"2009","journal-title":"Nature neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0555","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","article-title":"Regulation of cholesterol and sphingomyelin metabolism by amyloid-\u03b2 and presenilin","volume":"7","author":"Grimm","year":"2005","journal-title":"Nature cell biology"},{"key":"10.1016\/j.arr.2021.101451_bib0560","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s12035-015-9218-y","article-title":"Factors responsible for plasma \u03b2-amyloid accumulation in chronic kidney disease","volume":"53","author":"Gronewold","year":"2016","journal-title":"Molecular neurobiology"},{"key":"10.1016\/j.arr.2021.101451_bib0565","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00401-016-1596-3","article-title":"Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer\u2019s disease","volume":"132","author":"Gu","year":"2016","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib0570","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13195-021-00779-7","article-title":"Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer\u2019s disease progression based on the \"brain-gut\" axis through multiple integrated omics","volume":"13","author":"Gu","year":"2021","journal-title":"Alzheimer\u2019s research & therapy"},{"key":"10.1016\/j.arr.2021.101451_bib0575","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1074\/jbc.M111.315051","article-title":"Amyloid Precursor Protein Revisited Neuron-specific expression and highly stable nature of soluble derivatives","volume":"287","author":"Guo","year":"2012","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0580","article-title":"Florbetaben PET in the early diagnosis of alzheimer\u2019s disease: a discrete event simulation to explore its potential value and key data gaps","volume":"2012","author":"Guo","year":"2012","journal-title":"International journal of Alzheimer\u2019s disease"},{"key":"10.1016\/j.arr.2021.101451_bib0585","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3233\/JAD-190666","article-title":"Evaluation of peripheral immune dysregulation in alzheimer\u2019s disease and vascular dementia","volume":"71","author":"Guo","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arr.2021.101451_bib0590","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12031-018-1189-9","article-title":"Intracerebroventricular a\u03b2-induced neuroinflammation alters peripheral immune responses in rats","volume":"66","author":"Gupta","year":"2018","journal-title":"Journal of molecular neuroscience : MN"},{"key":"10.1016\/j.arr.2021.101451_bib0595","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity","volume":"80","author":"Haag","year":"2009","journal-title":"The Rotterdam Study. Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib0600","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1523\/JNEUROSCI.11-12-03783.1991","article-title":"Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion","volume":"11","author":"Haass","year":"1991","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0605","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","article-title":"Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic","volume":"14","author":"Hampel","year":"2018","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0610","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fnins.2018.00585","article-title":"Imaging protein misfolding in the brain using \u03b2-Sheet ligands","volume":"12","author":"Harada","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.arr.2021.101451_bib0615","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3233\/JAD-142853","article-title":"Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer\u2019s disease","volume":"48","author":"Harris","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.arr.2021.101451_bib0620","series-title":"Aging Mechanisms","first-page":"319","article-title":"Catabolism and anabolism of amyloid-\u03b2","author":"Hashimoto","year":"2015"},{"key":"10.1016\/j.arr.2021.101451_bib0625","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041636","article-title":"Disruption of arterial perivascular drainage of amyloid-\u03b2 from the brains of mice expressing the human APOE \u03b54 allele","volume":"7","author":"Hawkes","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.arr.2021.101451_bib0635","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0b013e31823b4765","article-title":"Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study","volume":"77","author":"Helmer","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0640","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid \u03b2-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0645","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0169-409X(02)00158-8","article-title":"Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer\u2019s disease","volume":"54","author":"Holtzman","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.arr.2021.101451_bib0650","series-title":"Role of a \u03b2 Transport and Clearance in the Pathogenesis and Treatment of Alzheimer\u2019s Disease, Alzheimer\u2019s Disease","first-page":"179","author":"Holtzman","year":"2007"},{"key":"10.1016\/j.arr.2021.101451_bib0655","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/03007995.2016.1277197","article-title":"Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer\u2019s disease - the case of florbetapir","volume":"33","author":"Hornberger","year":"2017","journal-title":"Current medical research and opinion"},{"key":"10.1016\/j.arr.2021.101451_bib0660","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnins.2016.00177","article-title":"One for all? Hitting multiple Alzheimer\u2019s disease targets with one drug","volume":"10","author":"Hughes","year":"2016","journal-title":"Frontiers in neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0665","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/glia.10148","article-title":"Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system","volume":"40","author":"Husemann","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.arr.2021.101451_bib0670","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Science translational medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0675","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/iub.2203","article-title":"Albumin domain mutants with enhanced A\u03b2 binding capacity identified by phage display analysis for application in various peripheral A\u03b2 elimination approaches of Alzheimer\u2019s disease treatment","volume":"72","author":"Ishima","year":"2020","journal-title":"IUBMB life"},{"key":"10.1016\/j.arr.2021.101451_bib0680","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/j.1471-4159.2007.04938.x","article-title":"Cerebral clearance of human amyloid\u2010\u03b2 peptide (1\u201340) across the blood\u2013brain barrier is reduced by self\u2010aggregation and formation of low\u2010density lipoprotein receptor\u2010related protein\u20101 ligand complexes","volume":"103","author":"Ito","year":"2007","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0685","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1471-4159.2010.06708.x","article-title":"Lack of brain\u2010to\u2010blood efflux transport activity of low\u2010density lipoprotein receptor\u2010related protein\u20101 (LRP\u20101) for amyloid\u2010\u03b2 peptide (1\u201340) in mouse: involvement of an LRP\u20101\u2010independent pathway","volume":"113","author":"Ito","year":"2010","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0690","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1126\/science.1059946","article-title":"Metabolic regulation of brain A\u03b2 by neprilysin","volume":"292","author":"Iwata","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib0695","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10571-019-00651-1","article-title":"Apolipoprotein e polymorphism and oxidative stress in peripheral blood-derived macrophage-mediated amyloid-beta phagocytosis in alzheimer\u2019s disease patients","volume":"39","author":"Jairani","year":"2019","journal-title":"Cellular and molecular neurobiology"},{"key":"10.1016\/j.arr.2021.101451_bib0700","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the. Beta. Amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease","volume":"32","author":"Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2021.101451_bib0705","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/CIRCULATIONAHA.114.012438","article-title":"Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study","volume":"131","author":"Jefferson","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2021.101451_bib0710","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of A\u03b2","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib0715","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3233\/JAD-170088","article-title":"Reduced cardiovascular functions in patients with Alzheimer\u2019s disease","volume":"58","author":"Jin","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.arr.2021.101451_bib0720","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-017-1721-y","article-title":"Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP\/PS1 mouse model","volume":"134","author":"Jin","year":"2017","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib0725","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/341226a0","article-title":"Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease","volume":"341","author":"Joachim","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib0730","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/341226a0","article-title":"Amyloid \u03b2-protein deposition in tissues other than brain in Alzheimer\u2019s disease","volume":"341","author":"Joachim","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib0735","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jalz.2018.04.003","article-title":"Peripheral complement interactions with amyloid \u03b2 peptide in Alzheimer\u2019s disease: polymorphisms, structure, and function of complement receptor 1","volume":"14","author":"Johansson","year":"2018","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer\u2019s Association"},{"key":"10.1016\/j.arr.2021.101451_bib0740","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11481-012-9427-3","article-title":"Amyloid-\u03b2-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE","volume":"8","author":"Jones","year":"2013","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.arr.2021.101451_bib0745","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jalz.2007.08.004","article-title":"Inflammation and Alzheimer\u2019s disease: possible role of periodontal diseases","volume":"4","author":"Kamer","year":"2008","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.arr.2021.101451_bib0750","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Frontiers in aging neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0755","doi-asserted-by":"crossref","first-page":"19276","DOI":"10.1523\/JNEUROSCI.3487-13.2013","article-title":"Neuronal clearance of amyloid-\u03b2 by endocytic receptor LRP1","volume":"33","author":"Kanekiyo","year":"2013","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0760","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib0765","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3349\/ymj.2017.58.3.479","article-title":"Metabolism-centric overview of the pathogenesis of alzheimer\u2019s disease","volume":"58","author":"Kang","year":"2017","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.arr.2021.101451_bib0770","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","article-title":"The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor","volume":"325","author":"Kang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib0775","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-016-0076-1","article-title":"Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis","volume":"4","author":"Kayano","year":"2016","journal-title":"Biomarker research"},{"key":"10.1016\/j.arr.2021.101451_bib0780","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1096\/fj.09-148825","article-title":"Glutamate carboxypeptidase II: an amyloid peptide\u2010degrading enzyme with physiological function in the brain","volume":"24","author":"Kim","year":"2010","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.arr.2021.101451_bib0785","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201807965","article-title":"Magnetite\/Ceria nanoparticle assemblies for extracorporeal cleansing of Amyloid-\u03b2 in alzheimer\u2019s disease","volume":"31","author":"Kim","year":"2019","journal-title":"Advanced materials (Deerfield Beach, Fla.)"},{"key":"10.1016\/j.arr.2021.101451_bib0790","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","article-title":"Peripheral inflammation in prodromal Alzheimer\u2019s and Lewy body dementias","volume":"89","author":"King","year":"2018","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib0795","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/331530a0","article-title":"Novel precursor of Alzheimer\u2019s disease amyloid protein shows protease inhibitory activity","volume":"331","author":"Kitaguchi","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib0800","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Science translational medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0805","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arr.2021.101451_bib0810","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nature medicine"},{"key":"10.1016\/j.arr.2021.101451_bib0815","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","article-title":"Risk of incident Alzheimer\u2019s disease in diabetic patients: a systematic review of prospective trials","volume":"16","author":"Kopf","year":"2009","journal-title":"Journal of Alzheimer\u2019s disease"},{"key":"10.1016\/j.arr.2021.101451_bib0820","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000335154","article-title":"Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment","volume":"10","author":"Koronyo","year":"2012","journal-title":"Neuro-degenerative diseases"},{"key":"10.1016\/j.arr.2021.101451_bib0825","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/brain\/awv150","article-title":"Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer\u2019s disease","volume":"138","author":"Koronyo","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.arr.2021.101451_bib0830","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Annals of neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0835","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neurobiolaging.2020.02.001","article-title":"A novel role for SHARPIN in amyloid-\u03b2 phagocytosis and inflammation by peripheral blood-derived macrophages in Alzheimer\u2019s disease","volume":"93","author":"Krishnan","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arr.2021.101451_bib0840","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1093\/hmg\/ddx267","article-title":"MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer\u2019s disease","volume":"26","author":"Kumar","year":"2017","journal-title":"Human molecular genetics"},{"key":"10.1016\/j.arr.2021.101451_bib0845","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1006\/bbrc.1999.0552","article-title":"High levels of circulating A\u03b242 are sequestered by plasma proteins in Alzheimer\u2019s disease","volume":"257","author":"Kuo","year":"1999","journal-title":"Biochem. Biophysical Res. Comm."},{"key":"10.1016\/j.arr.2021.101451_bib0850","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-\u03b2 peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem. Biophysical Res. Comm."},{"key":"10.1016\/j.arr.2021.101451_bib0855","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bbrc.2000.2222","article-title":"Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma","volume":"268","author":"Kuo","year":"2000","journal-title":"Biochem. Biophysical Res. Comm."},{"key":"10.1016\/j.arr.2021.101451_bib0860","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","article-title":"Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism","volume":"156","author":"Kuo","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2021.101451_bib0865","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroscience.2020.05.004","article-title":"Mouse bone marrow-derived microglia-like cells secrete transforming growth Factor-\u03b21 and promote microglial a\u03b2 phagocytosis and reduction of brain a\u03b2","volume":"438","author":"Kuroda","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib0870","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-190974","article-title":"Peripheral blood-derived microglia-like cells decrease Amyloid-\u03b2 burden and ameliorate cognitive impairment in a mouse model of alzheimer\u2019s disease","volume":"73","author":"Kuroda","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arr.2021.101451_bib0875","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1007\/s12035-020-02106-x","article-title":"Altered expression of long non-coding RNAs in peripheral blood mononuclear cells of patients with alzheimer\u2019s disease","volume":"57","author":"Kurt","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.arr.2021.101451_bib0880","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib0885","doi-asserted-by":"crossref","first-page":"9651","DOI":"10.1523\/JNEUROSCI.0329-10.2010","article-title":"Trafficking CD11b-positive blood cells deliver therapeutic genes to the brain of amyloid-depositing transgenic mice","volume":"30","author":"Lebson","year":"2010","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib0890","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/embo-reports\/kvd107","article-title":"Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer\u2019s disease brains","volume":"1","author":"Ledesma","year":"2000","journal-title":"EMBO reports"},{"key":"10.1016\/j.arr.2021.101451_bib0895","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","article-title":"The role of microglia in amyloid clearance from the AD brain","volume":"117","author":"Lee","year":"2010","journal-title":"J. Neural Transmission"},{"key":"10.1016\/j.arr.2021.101451_bib0900","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","article-title":"Apolipoprotein E promotes \u03b2-amyloid trafficking and degradation by modulating microglial cholesterol levels","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib0905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0299-y","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exper. Mol. Med."},{"key":"10.1016\/j.arr.2021.101451_bib0910","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib0915","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","article-title":"Can Alzheimer disease be prevented by amyloid-beta immunotherapy?","volume":"6","author":"Lemere","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.arr.2021.101451_bib0920","series-title":"Membrane-associated Forms of the Beta A4 Amyloid Protein Precursor of Alzheimer\u2019s Disease in Human Platelet and Brain: Surface Expression on the Activated Human Platelet","author":"Li","year":"1994"},{"key":"10.1016\/j.arr.2021.101451_bib0925","first-page":"461","article-title":"Secretion of Alzheimer\u2019s disease A\u00df amyloid peptide","volume":"78","author":"Li","year":"1998","journal-title":"Lab. Invest"},{"key":"10.1016\/j.arr.2021.101451_bib0930","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/153331759801300504","article-title":"Products of the Alzheimer\u2019s disease amyloid precursor protein generated by, \u03b2-secretase are present in human platelets, and secreted upon degranulation","volume":"13","author":"Li","year":"1998","journal-title":"Am. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib0935","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jlb.66.4.567","article-title":"The amyloid precursor protein of Alzheimer disease in human brain and blood","volume":"66","author":"Li","year":"1999","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.arr.2021.101451_bib0940","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.neurobiolaging.2007.10.011","article-title":"Hypoxia increases A\u03b2 generation by altering \u03b2-and \u03b3-cleavage of APP","volume":"30","author":"Li","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101451_bib0945","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/WNL.0b013e318217e7a4","article-title":"Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease","volume":"76","author":"Li","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib0950","doi-asserted-by":"crossref","first-page":"44593","DOI":"10.1074\/jbc.M112.420224","article-title":"Differential regulation of amyloid-\u03b2 endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms","volume":"287","author":"Li","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib0955","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1128\/MCB.00544-13","article-title":"P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia","volume":"33","author":"Li","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.arr.2021.101451_bib0960","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bone.2014.01.010","article-title":"Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function","volume":"61","author":"Li","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.arr.2021.101451_bib0965","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11011-019-00497-y","article-title":"Profiling of differentially expressed circular RNAs in peripheral blood mononuclear cells from Alzheimer\u2019s disease patients","volume":"35","author":"Li","year":"2020","journal-title":"Metabolic Brain Dis."},{"key":"10.1016\/j.arr.2021.101451_bib0970","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","article-title":"Blood and plasma-based proteomic biomarker research in Alzheimer\u2019s disease","volume":"101","author":"Lista","year":"2013","journal-title":"Progress in Neurobiol."},{"key":"10.1016\/j.arr.2021.101451_bib0975","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/mt.2009.115","article-title":"Expression of neprilysin in skeletal muscle reduces amyloid burden in a transgenic mouse model of Alzheimer disease","volume":"17","author":"Liu","year":"2009","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.arr.2021.101451_bib0980","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-2011-111472","article-title":"Characterization of insulin degrading enzyme and other amyloid-\u03b2 degrading proteases in human serum: a role in Alzheimer\u2019s disease?","volume":"29","author":"Liu","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib0985","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2014.05.004","article-title":"Dysfunctional Wnt\/beta-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer\u2019s disease","volume":"75","author":"Liu","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.arr.2021.101451_bib0990","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12035-014-8854-y","article-title":"Association between serum amyloid-beta and renal functions: implications for roles of kidney in amyloid-beta clearance","volume":"52","author":"Liu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101451_bib0995","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.601965","article-title":"Identification of circular RNA hsa_Circ_0003391 in peripheral blood is potentially associated with alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.arr.2021.101451_bib1000","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12264-013-1410-3","article-title":"Lipid metabolism in Alzheimer\u2019s disease","volume":"30","author":"Liu","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.arr.2021.101451_bib1005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1015","series-title":"Contribution of Cerebral Amyloid Angiopathy to Alzheimer\u2019s Disease","author":"Love","year":"2004"},{"key":"10.1016\/j.arr.2021.101451_bib1020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jalz.2016.12.004","article-title":"Plasma concentrations of free amyloid \u03b2 cannot predict the development of Alzheimer\u2019s disease","volume":"13","author":"L\u00f6vheim","year":"2017","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.arr.2021.101451_bib1025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/mp.2017.136","article-title":"Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer\u2019s disease and mild cognitive impairment","volume":"23","author":"Lu","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib1030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","article-title":"Aggregation of vascular risk factors and risk of incident Alzheimer disease","volume":"65","author":"Luchsinger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1040","doi-asserted-by":"crossref","first-page":"21702","DOI":"10.1021\/jacs.0c08395","article-title":"Self-protecting biomimetic nanozyme for selective and synergistic clearance of peripheral Amyloid-\u03b2 in an alzheimer\u2019s disease model","volume":"142","author":"Ma","year":"2020","journal-title":"J. American Chem. Soc."},{"key":"10.1016\/j.arr.2021.101451_bib1045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1172\/JCI2029","article-title":"Human blood-brain barrier receptors for Alzheimer\u2019s amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer","volume":"102","author":"Mackic","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2021.101451_bib1050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1471-4159.1998.70010210.x","article-title":"Cerebrovascular accumulation and increased blood\u2010brain barrier permeability to circulating Alzheimer\u2019s amyloid \u03b2 peptide in aged squirrel monkey with cerebral amyloid angiopathy","volume":"70","author":"Mackic","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101451_bib1055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1537-1891(02)00198-2","article-title":"Circulating amyloid-\u03b2 peptide crosses the blood\u2013brain barrier in aged monkeys and contributes to Alzheimer\u2019s disease lesions","volume":"38","author":"Mackic","year":"2002","journal-title":"Vascular Pharmacol."},{"key":"10.1016\/j.arr.2021.101451_bib1060","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","article-title":"Microglia mediate the clearance of soluble A\u03b2 through fluid phase macropinocytosis","volume":"29","author":"Mandrekar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1065","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1474-4422(10)70119-8","article-title":"Alzheimer\u2019s disease: clinical trials and drug development","volume":"9","author":"Mangialasche","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1070","first-page":"1257","article-title":"Predominant deposition of amyloid-beta 42 (43) in plaques in cases of Alzheimer\u2019s disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene","volume":"148","author":"Mann","year":"1996","journal-title":"American J. Pathol."},{"key":"10.1016\/j.arr.2021.101451_bib1075","first-page":"10","article-title":"Curcugreen treatment prevented splenomegaly and other peripheral organ abnormalities in 3xTg and 5xFAD mouse models of alzheimer\u2019s disease","author":"Manna","year":"2021","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.arr.2021.101451_bib1080","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1085","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1471-4159.2009.06408.x","article-title":"Cholesterol metabolism and transport in the pathogenesis of Alzheimer\u2019s disease","volume":"111","author":"Martins","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101451_bib1090","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nature Rev. Dis. Primers"},{"key":"10.1016\/j.arr.2021.101451_bib1095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/j.semnuclmed.2012.07.001","article-title":"Development of positron emission tomography \u03b2-amyloid plaque imaging agents","volume":"42","author":"Mathis","year":"2012","journal-title":"Seminars Nuclear Medicine"},{"key":"10.1016\/j.arr.2021.101451_bib1100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.semnuclmed.2017.06.003","article-title":"Small-molecule PET tracers for imaging proteinopathies","volume":"47","author":"Mathis","year":"2017","journal-title":"Seminars Nuclear Medicine"},{"key":"10.1016\/j.arr.2021.101451_bib1105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1523\/JNEUROSCI.23-01-00029.2003","article-title":"Novel therapeutic approach for the treatment of Alzheimer\u2019s disease by peripheral administration of agents with an affinity to \u03b2-amyloid","volume":"23","author":"Matsuoka","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1110","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1212\/WNL.0b013e31822e145d","article-title":"Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study","volume":"77","author":"Matsuzaki","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1115","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","volume":"87","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1125","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib1130","doi-asserted-by":"crossref","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101451_bib1135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1027325304203","article-title":"Degradation of alzheimer\u2019s \u00df-Amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme","volume":"22","author":"McDermott","year":"1997","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.arr.2021.101451_bib1140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","article-title":"Amyloid \u03b2 protein 1\u201340 and 1\u201342 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease","volume":"304","author":"Mehta","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2021.101451_bib1145","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1523\/JNEUROSCI.23-26-08867.2003","article-title":"The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-\u03b2 (A\u03b2) degradation and inhibits A\u03b2-induced neurodegeneration","volume":"23","author":"Melchor","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10456-018-9608-7","article-title":"Peripheral post-ischemic vascular repair is impaired in a murine model of Alzheimer\u2019s disease","volume":"21","author":"Merkulova-Rainon","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.arr.2021.101451_bib1155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","article-title":"Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta","volume":"5","author":"Michaud","year":"2013","journal-title":"Cell reports"},{"key":"10.1016\/j.arr.2021.101451_bib1160","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/db12-0209","article-title":"Mitochondria, diabetes, and Alzheimer\u2019s disease","volume":"61","author":"Milone","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.arr.2021.101451_bib1165","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","article-title":"Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy","volume":"65","author":"Miners","year":"2006","journal-title":"J. Neuropathol. Exper. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"Abeta-degrading enzymes in Alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain Pathol"},{"key":"10.1016\/j.arr.2021.101451_bib1175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1750-3639.2008.00132.x","article-title":"SYMPOSIUM: clearance of a\u03b2 from the brain in alzheimer\u2019s disease: a\u03b2\u2010degrading enzymes in alzheimer\u2019s disease","volume":"18","author":"Miners","year":"2008","journal-title":"Brain pathology"},{"key":"10.1016\/j.arr.2021.101451_bib1180","doi-asserted-by":"crossref","first-page":"23950","DOI":"10.1016\/S0021-9258(18)35929-5","article-title":"Alzheimer beta A4-amyloid protein precursor in immunocompetent cells","volume":"267","author":"M\u00f6nning","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib1185","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood\u2013brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J. Exper. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1190","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-021-01150-w","article-title":"Transmission of cerebral amyloid pathology by peripheral administration of misfolded A\u03b2 aggregates","author":"Morales","year":"2021","journal-title":"Mol Psychiatry."},{"key":"10.1016\/j.arr.2021.101451_bib1195","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","article-title":"Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding","volume":"22","author":"Moreno-Gonzalez","year":"2017","journal-title":"Molecular psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib1200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1365-2796.2010.02315.x","article-title":"Immunotherapy for Alzheimer\u2019s disease","volume":"269","author":"Morgan","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.arr.2021.101451_bib1205","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2174\/1567205015666180404165915","article-title":"Platelet tau protein as a potential peripheral biomarker in alzheimer\u2019s disease: an explorative study","volume":"15","author":"Mukaetova-Ladinska","year":"2018","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.arr.2021.101451_bib1210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12979-021-00236-x","article-title":"Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer\u2019s disease","volume":"18","author":"Munawara","year":"2021","journal-title":"Immunity & ageing : I & A"},{"key":"10.1016\/j.arr.2021.101451_bib1215","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1326-8-S1-P33","article-title":"LRP1 plays a major role in the amyloid-\u03b2 clearance in microglia","volume":"8","author":"N\u2019Songo","year":"2013","journal-title":"Mol. Neurodegeneration"},{"key":"10.1016\/j.arr.2021.101451_bib1220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(03)02361-8","article-title":"Astrocytes accumulate A\u03b242 and give rise to astrocytic amyloid plaques in Alzheimer disease brains","volume":"971","author":"Nagele","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2021.101451_bib1225","series-title":"Alzheimer Patients Show Significant Disturbance in Water Influx Into CSF Space Strongly Supporting \u03b2-amyloid Clearance Hypothesis (S58. 001)","author":"Nakada","year":"2014"},{"key":"10.1016\/j.arr.2021.101451_bib1230","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1471-4159.2011.07510.x","article-title":"Are amyloid\u2010degrading enzymes viable therapeutic targets in Alzheimer\u2019s disease?","volume":"120","author":"Nalivaeva","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101451_bib1240","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04716","article-title":"Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer\u2019s disease","volume":"6","author":"Neshan","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2021.101451_bib1245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7978","article-title":"Association of altered liver enzymes with alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers","volume":"2","author":"Nho","year":"2019","journal-title":"JAMA network open"},{"key":"10.1016\/j.arr.2021.101451_bib1250","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-150910","article-title":"Associations between serum omega-3 fatty acid levels and cognitive functions among community-dwelling octogenarians in Okinawa, Japan: the KOCOA study","volume":"51","author":"Nishihira","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(00)02076-7","article-title":"Regulation of APP cleavage by \u03b1-, \u03b2-and \u03b3-secretases","volume":"483","author":"Nunan","year":"2000","journal-title":"FEBS letters"},{"key":"10.1016\/j.arr.2021.101451_bib1260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease","volume":"34","author":"O\u2019brien","year":"2011","journal-title":"Annual Rev. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2014.09.015","article-title":"Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-\u03b2 levels in APP\/PS1 transgenic mice","volume":"11","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2015","journal-title":"Nanomedicine: Nanotechnology, Biology Medicine"},{"key":"10.1016\/j.arr.2021.101451_bib1270","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/WNL.0000000000001566","article-title":"Sleep-disordered breathing advances cognitive decline in the elderly","volume":"84","author":"Osorio","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1275","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neubiorev.2009.05.006","article-title":"Alzheimer\u2019s disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression?","volume":"33","author":"Pahnke","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.arr.2021.101451_bib1280","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2174\/1567205017666201006162538","article-title":"Alterations in mitochondrial dynamic-related genes in the peripheral blood of alzheimer\u2019s disease patients","volume":"17","author":"Pakpian","year":"2020","journal-title":"Current Alzheimer Res."},{"key":"10.1016\/j.arr.2021.101451_bib1285","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of fully automated plasma assays as screening tests for alzheimer disease-related beta-amyloid status","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1290","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2021.101451_bib1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1326-6-45","article-title":"Microglial phagocytosis induced by fibrillar \u03b2-amyloid is attenuated by oligomeric \u03b2-amyloid: implications for Alzheimer\u2019s disease","volume":"6","author":"Pan","year":"2011","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.arr.2021.101451_bib1300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/imt.11.170","article-title":"Immunotherapy for Alzheimer\u2019s disease: from anti-\u03b2-amyloid to tau-based immunization strategies","volume":"4","author":"Panza","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.arr.2021.101451_bib1305","doi-asserted-by":"crossref","first-page":"42781","DOI":"10.1074\/jbc.M207601200","article-title":"ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells","volume":"277","author":"Panzenboeck","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib1310","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neurobiolaging.2013.07.010","article-title":"Selective benefits of simvastatin in bitransgenic APPSwe, Ind\/TGF-\u03b21 mice","volume":"35","author":"Papadopoulos","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101451_bib1315","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0896-6273(00)80187-7","article-title":"Microglial cells internalize aggregates of the Alzheimer\u2019s disease amyloid \u03b2-protein via a scavenger receptor","volume":"17","author":"Paresce","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib1320","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-180802","article-title":"Understanding the amyloid hypothesis in Alzheimer\u2019s disease","volume":"68","author":"Paroni","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.arr.2021.101451_bib1330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8","author":"Pascale","year":"2011","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.arr.2021.101451_bib1335","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0924-977X(02)00098-6","article-title":"Blood\u2013brain barrier, brain metabolism and cerebral blood flow","volume":"12","author":"Paulson","year":"2002","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.arr.2021.101451_bib1340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-131544","article-title":"Late-onset Alzheimer\u2019s disease, heating up and foxed by several proteins: pathomolecular effects of the aging process","volume":"40","author":"Perez","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1345","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.wad.0000194014.43575.fd","article-title":"Safety and acceptability of the research lumbar puncture","volume":"19","author":"Peskind","year":"2005","journal-title":"Alzheimer Dis. Associated Disorders"},{"key":"10.1016\/j.arr.2021.101451_bib1350","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5858\/2001-125-0038-TCCOA","article-title":"The changing concepts of amyloid","volume":"125","author":"Picken","year":"2001","journal-title":"Archiv. Pathol. Laboratory Med."},{"key":"10.1016\/j.arr.2021.101451_bib1355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The glymphatic system in central nervous system health and disease: past, present, and future","volume":"13","author":"Plog","year":"2018","journal-title":"Ann. Rev. Pathol. Mechan. Disease"},{"key":"10.1016\/j.arr.2021.101451_bib1360","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/331525a0","article-title":"A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors","volume":"331","author":"Ponte","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1365","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2990.2003.00424.x","article-title":"Capillary and arterial cerebral amyloid angiopathy in Alzheimer\u2019s disease: defining the perivascular route for the elimination of amyloid \u03b2 from the human brain","volume":"29","author":"Preston","year":"2003","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.arr.2021.101451_bib1370","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101317","article-title":"Inflammatory pathways in Alzheimer\u2019s disease mediated by gut microbiota","author":"Qian","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2021.101451_bib1375","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib1380","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archinte.166.9.1003","article-title":"Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study","volume":"166","author":"Qiu","year":"2006","journal-title":"Archiv. Inter. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1385","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-\u03b2 clearance across mouse and human blood\u2013brain barrier models: kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2021.101451_bib1390","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Mechanisms of disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"New England J. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1395","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1400","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fneur.2017.00328","article-title":"Study on analysis of peripheral biomarkers for alzheimer\u2019s disease diagnosis","volume":"8","author":"Rani","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaneurol.2013.5390","article-title":"Associations between serum cholesterol levels and cerebral amyloidosis","volume":"71","author":"Reed","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1410","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of A\u03b2 clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1415","first-page":"510","article-title":"Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition","volume":"11","author":"Risacher","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.arr.2021.101451_bib1420","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2565","article-title":"Regulation of innate immune responses in the brain","volume":"9","author":"Rivest","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2021.101451_bib1425","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid \u03b2 peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101451_bib1430","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer\u2019s Association"},{"key":"10.1016\/j.arr.2021.101451_bib1435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archneur.1997.00550140019007","article-title":"Altered amyloid protein processing in platelets of patients with Alzheimer disease","volume":"54","author":"Rosenberg","year":"1997","journal-title":"Archiv. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1440","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0197-4580(98)00033-5","article-title":"Alzheimer\u2019s disease as proteolytic disorders: anabolism and catabolism of \u03b2-amyloid","volume":"19","author":"Saido","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101451_bib1445","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3233\/JAD-151139","article-title":"Patients that have undergone hemodialysis exhibit lower amyloid deposition in the brain: evidence supporting a therapeutic strategy for Alzheimer\u2019s disease by removal of blood amyloid","volume":"51","author":"Sakai","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1450","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1124\/jpet.116.237057","article-title":"Blood\u2013brain barrier disruption and neurovascular unit dysfunction in diabetic mice: protection with the mitochondrial carbonic anhydrase inhibitor topiramate","volume":"359","author":"Salameh","year":"2016","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"10.1016\/j.arr.2021.101451_bib1455","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0021-9258(17)42286-1","article-title":"Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons","volume":"269","author":"Sandbrink","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2021.101451_bib1460","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1504327","article-title":"Incidence of dementia over three decades in the Framingham Heart Study","volume":"374","author":"Satizabal","year":"2016","journal-title":"New England J. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnagi.2015.00199","article-title":"The roles of lipid and glucose metabolism in modulation of \u03b2-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease","volume":"7","author":"Sato","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1470","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006387","article-title":"Treatment strategies targeting amyloid beta-protein","volume":"2","author":"Schenk","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.arr.2021.101451_bib1475","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(91)91532-6","article-title":"Localization of Alzheimer \u03b2A4 amyloid precursor protein at central and peripheral synaptic sites","volume":"563","author":"Schubert","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2021.101451_bib1480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0047-6374(94)90023-X","article-title":"Alzheimer\u2019s disease and Down syndrome: leukocyte membrane fluidity alterations","volume":"75","author":"Scott","year":"1994","journal-title":"Mechan. Ageing Develop."},{"key":"10.1016\/j.arr.2021.101451_bib1485","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1490","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00005072-199409000-00003","article-title":"Alzheimer\u2019s disease: a central role for amyloid","volume":"53","author":"Selkoe","year":"1994","journal-title":"J. Neuropathol. Exper. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1495","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.arr.2021.101451_bib1500","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1073\/pnas.85.19.7341","article-title":"Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues","volume":"85","author":"Selkoe","year":"1988","journal-title":"Proc. Nat. Acad. Scie."},{"key":"10.1016\/j.arr.2021.101451_bib1505","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1073\/pnas.85.19.7341","article-title":"Beta-amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneural tissues","volume":"85","author":"Selkoe","year":"1988","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1510","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-2012-111964","article-title":"A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer\u2019s disease","volume":"30","author":"Serot","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1515","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1520","first-page":"460","article-title":"How do periodontal infections affect the onset and progression of Alzheimer\u2019s disease?","volume":"13","author":"Shaik","year":"2014","journal-title":"CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"10.1016\/j.arr.2021.101451_bib1525","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-\u03b2 1-40 peptide from brain by LDL receptor\u2013related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2021.101451_bib1530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.mrgentox.2018.03.001","article-title":"\u03b3H2AX is increased in peripheral blood lymphocytes of Alzheimer\u2019s disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging. Mutation research","volume":"829-830","author":"Siddiqui","year":"2018","journal-title":"Genetic Toxicol. Environ. Mutagenesis"},{"key":"10.1016\/j.arr.2021.101451_bib1535","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1523\/JNEUROSCI.1344-04.2004","article-title":"An attenuated immune response is sufficient to enhance cognition in an Alzheimer\u2019s disease mouse model immunized with amyloid-beta derivatives","volume":"24","author":"Sigurdsson","year":"2004","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1540","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer\u2019s disease, normal\u2010pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1545","first-page":"998","article-title":"Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia","volume":"18","author":"Simard","year":"2004","journal-title":"FASEB J. Off. Publ. Feder. American Soc. Exper. Biol."},{"key":"10.1016\/j.arr.2021.101451_bib1550","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"Simard","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib1555","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1523\/JNEUROSCI.16-03-00899.1996","article-title":"Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons","volume":"16","author":"Simons","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1560","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of \u03b2-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1565","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1100\/tsw.2009.99","article-title":"Immunotherapeutic strategies for Alzheimer\u2019s disease treatment","volume":"9","author":"Solomon","year":"2009","journal-title":"ScientificWorld J."},{"key":"10.1016\/j.arr.2021.101451_bib1570","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1073\/pnas.93.1.452","article-title":"Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide","volume":"93","author":"Solomon","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2021.101451_bib1575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","article-title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","volume":"85","author":"Sperling","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arr.2021.101451_bib1580","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jocn.2012.06.008","article-title":"The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer\u2019s disease in Thai patients","volume":"20","author":"Srisawat","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1585","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in A\u03b2 uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.arr.2021.101451_bib1590","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","article-title":"Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid \u03b2-peptide by the liver","volume":"23","author":"Tamaki","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.arr.2021.101451_bib1595","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","article-title":"Insulin facilitates the hepatic clearance of plasma amyloid beta-peptide (1 40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes","volume":"72","author":"Tamaki","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.arr.2021.101451_bib1600","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1124\/mol.107.036913","article-title":"Insulin facilitates the hepatic clearance of plasma amyloid \u03b2-peptide (1\u201340) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes","volume":"72","author":"Tamaki","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.arr.2021.101451_bib1605","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/331528a0","article-title":"Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer\u2019s disease","volume":"331","author":"Tanzi","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101451_bib1610","first-page":"605","article-title":"Clearance of Alzheimer\u2019s A\u03b2 peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2021.101451_bib1615","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain\u2014implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nature Review. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1620","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1533317517724000","article-title":"Undetected peripheral arterial disease among older adults with alzheimer\u2019s disease and other dementias","volume":"33","author":"Tasci","year":"2018","journal-title":"American J. Alzheimer\u2019s Dis. Other Dementias"},{"key":"10.1016\/j.arr.2021.101451_bib1625","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mad.2017.09.003","article-title":"Mitochondrial depletion in CD4(+) and CD19(+) peripheral lymphocytes in early stage Alzheimer\u2019s disease","volume":"167","author":"Terzio\u011flu","year":"2017","journal-title":"Mech. Ageing Dev"},{"key":"10.1016\/j.arr.2021.101451_bib1630","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1468-1331.2010.03273.x","article-title":"Brain\u2010specific fatty acid\u2010binding protein is elevated in serum of patients with dementia\u2010related diseases","volume":"18","author":"Teunissen","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1635","first-page":"1","article-title":"Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease","author":"Tian","year":"2021","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib1640","series-title":"Cold Spring Harbor Symposia on Quantitative Biology","first-page":"575","article-title":"Neuronal sorting and processing of amyloid precursor protein: implications for alzheimer\u2019s disease","author":"Tienari","year":"1996"},{"key":"10.1016\/j.arr.2021.101451_bib1645","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid \u03b2 peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2021.101451_bib1650","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","article-title":"Factors affecting A\u03b2 plasma levels and their utility as biomarkers in ADNI","volume":"122","author":"Toledo","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib1655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2013.10.065","article-title":"Incident ischaemic heart disease in persons with Alzheimer\u2019s disease in a Finnish nationwide exposure-matched cohort","volume":"170","author":"Tolppanen","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.arr.2021.101451_bib1660","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"A\u03b2 amyloid pathology affects the hearts of patients with alzheimer\u2019s disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J. American College Cardiol."},{"key":"10.1016\/j.arr.2021.101451_bib1665","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.trci.2019.06.008","article-title":"Alzheimer\u2019s disease mechanisms in peripheral cells: promises and challenges","volume":"5","author":"Trushina","year":"2019","journal-title":"Alzheimer\u2019s Dementia (New York, N. Y.)"},{"key":"10.1016\/j.arr.2021.101451_bib1670","series-title":"New Insights Into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection, International Review of Neurobiology","first-page":"113","author":"Turner","year":"2007"},{"key":"10.1016\/j.arr.2021.101451_bib1675","first-page":"1","article-title":"Peripheral leukocytosis predicts cognitive decline but not behavioral disturbances: a nationwide study of alzheimer\u2019s and parkinson\u2019s disease patients","author":"Unda","year":"2021","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.arr.2021.101451_bib1680","first-page":"276","article-title":"Expression analysis of beta-secretase 1 (BACE1) enzyme in peripheral blood of patients with Alzheimer\u2019s disease","volume":"10","author":"Vakilian","year":"2019","journal-title":"Caspian J. Int. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1685","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0079-6123(09)17509-X","article-title":"Toll-like receptors in the CNS: implications for neurodegeneration and repair","volume":"175","author":"van Noort","year":"2009","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.arr.2021.101451_bib1690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-291X(05)81193-3","article-title":"Protease nexin-2\/amyloid \u03b2-protein precursor in blood is a platelet-specific protein","volume":"175","author":"Van Nostrand","year":"1991","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"10.1016\/j.arr.2021.101451_bib1695","doi-asserted-by":"crossref","first-page":"13376","DOI":"10.1523\/JNEUROSCI.2788-07.2007","article-title":"Experimental investigation of antibody-mediated clearance mechanisms of amyloid-beta in CNS of Tg-SwDI transgenic mice","volume":"27","author":"Vasilevko","year":"2007","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"key":"10.1016\/j.arr.2021.101451_bib1700","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-014-1341-8","article-title":"A platelet protein biochip rapidly detects an Alzheimer\u2019s disease-specific phenotype","volume":"128","author":"Veitinger","year":"2014","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib1705","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid \u03b2-protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1710","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1192\/bjp.bp.109.067942","article-title":"Risk of developing dementia in people with diabetes and mild cognitive impairment","volume":"196","author":"Velayudhan","year":"2010","journal-title":"British J. Psychiatry"},{"key":"10.1016\/j.arr.2021.101451_bib1715","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fphys.2018.00169","article-title":"Impact of nitric oxide bioavailability on the progressive cerebral and peripheral circulatory impairments during aging and alzheimer\u2019s disease","volume":"9","author":"Venturelli","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.arr.2021.101451_bib1720","first-page":"175","article-title":"Selective tau imaging: der stand der dinge","volume":"59","author":"Villemagne","year":"2018","journal-title":"J. Nuclear Med. Off. Publ. Soc. Nuclear Med."},{"key":"10.1016\/j.arr.2021.101451_bib1725","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-2012-111736","article-title":"Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study","volume":"31","author":"Wallin","year":"2012","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1730","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrneurol.2014.44","article-title":"Alzheimer disease: lessons from immunotherapy for Alzheimer disease","volume":"10","author":"Wang","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1735","article-title":"Screening and identification of potential peripheral blood biomarkers for alzheimer\u2019s disease based on bioinformatics analysis","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Monitor Intern. Med. J. Exper. Clin. Res."},{"key":"10.1016\/j.arr.2021.101451_bib1740","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.arr.2021.101451_bib1745","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","article-title":"Associations between hepatic functions and plasma amyloid-beta levels\u2014implications for the capacity of liver in peripheral amyloid-beta clearance","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101451_bib1750","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3348\/kjr.2018.19.3.498","article-title":"Blood-brain barrier disruption and perivascular beta-amyloid accumulation in the brain of aged rats with spontaneous hypertension: evaluation with dynamic contrast-enhanced magnetic resonance imaging","volume":"19","author":"Wang","year":"2018","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.arr.2021.101451_bib1755","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-020-00395-3","article-title":"Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.arr.2021.101451_bib1760","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129709014379","article-title":"Complement interactions with amyloid \u03b21\u201342: a nidus for inflammation in AD brains","volume":"4","author":"Watson","year":"1997","journal-title":"Amyloid : the international journal of experimental and clinical investigation : official journal of the International Society of Amyloidosis"},{"key":"10.1016\/j.arr.2021.101451_bib1765","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain pathology (Zurich, Switzerland)"},{"key":"10.1016\/j.arr.2021.101451_bib1770","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"SYMPOSIUM: clearance of a\u03b2 from the brain in alzheimer\u2019s disease: perivascular drainage of Amyloid-\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathology"},{"key":"10.1016\/j.arr.2021.101451_bib1775","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"SYMPOSIUM: clearance of a\u03b2 from the brain in alzheimer\u2019s disease: perivascular drainage of Amyloid\u2010\u03b2 peptides from the brain and its failure in cerebral amyloid angiopathy and alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathology"},{"key":"10.1016\/j.arr.2021.101451_bib1780","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00401-015-1416-1","article-title":"Does the difference between PART and Alzheimer\u2019s disease lie in the age-related changes in cerebral arteries that trigger the accumulation of A\u03b2 and propagation of tau?","volume":"129","author":"Weller","year":"2015","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib1785","first-page":"63","article-title":"Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile","volume":"3","author":"Winston","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1016\/j.arr.2021.101451_bib1790","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1111\/j.1742-4658.2008.06515.x","article-title":"D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration","volume":"275","author":"Wolosker","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.arr.2021.101451_bib1795","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.18632\/aging.202662","article-title":"Platelets transport \u03b2-amyloid from the peripheral blood into the brain by destroying the blood-brain barrier to accelerate the process of Alzheimer\u2019s disease in mouse models","volume":"13","author":"Wu","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.arr.2021.101451_bib1800","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-015-1477-1","article-title":"Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer\u2019s disease","volume":"130","author":"Xiang","year":"2015","journal-title":"Acta neuropathologica"},{"key":"10.1016\/j.arr.2021.101451_bib1805","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4505720","article-title":"Differential expression of mRNAs in peripheral blood related to prodrome and progression of alzheimer\u2019s disease","volume":"2020","author":"Xue","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.arr.2021.101451_bib1810","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJM199112263252605","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. Beta-Amyloid and the pathogenesis of Alzheimer\u2019s disease","volume":"325","author":"Yankner","year":"1991","journal-title":"New England J. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1815","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamaneurol.2016.1924","article-title":"Association of serum docosahexaenoic acid with cerebral amyloidosis","volume":"73","author":"Yassine","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101451_bib1820","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Therapeutic Advances Neurol. Dis."},{"key":"10.1016\/j.arr.2021.101451_bib1825","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.arr.2021.101451_bib1830","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","article-title":"Mechanisms of amyloid-beta peptide clearance: potential therapeutic targets for alzheimer\u2019s disease","volume":"20","author":"Yoon","year":"2012","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1016\/j.arr.2021.101451_bib1835","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-013-0187-4","article-title":"Developing therapeutic antibodies for neurodegenerative disease","volume":"10","author":"Yu","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2021.101451_bib1840","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","article-title":"Apolipoprotein E in Alzheimer\u2019s disease: an update","volume":"37","author":"Yu","year":"2014","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1845","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.20151428","article-title":"Rapid in vivo measurement of \u03b2-amyloid reveals biphasic clearance kinetics in an Alzheimer\u2019s mouse model","volume":"213","author":"Yuede","year":"2016","journal-title":"J. Exper. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1850","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.20151428","article-title":"Rapid in vivo measurement of beta-amyloid reveals biphasic clearance kinetics in an Alzheimer\u2019s mouse model","volume":"213","author":"Yuede","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2021.101451_bib1855","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote Alzheimer\u2019s disease\u2013like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nature Med."},{"key":"10.1016\/j.arr.2021.101451_bib1860","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1212\/WNL.0000000000003391","article-title":"Gram-negative bacterial molecules associate with Alzheimer disease pathology","volume":"87","author":"Zhan","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101451_bib1865","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer\u2019s disease brain: a review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1870","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1073858410381532","article-title":"Sink hypothesis and therapeutic strategies for attenuating Abeta levels","volume":"17","author":"Zhang","year":"2011","journal-title":"Neuroscientist"},{"key":"10.1016\/j.arr.2021.101451_bib1875","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/abbs\/gmp031","article-title":"The lysosome and neurodegenerative diseases","volume":"41","author":"Zhang","year":"2009","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.arr.2021.101451_bib1880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Molecular brain"},{"key":"10.1016\/j.arr.2021.101451_bib1885","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-6606-4-3","article-title":"APP processing in Alzheimer\u2019s disease","volume":"4","author":"Zhang","year":"2011","journal-title":"Molecular brain"},{"key":"10.1016\/j.arr.2021.101451_bib1890","first-page":"1","article-title":"Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer\u2019s disease (AD)","author":"Zhao","year":"2015","journal-title":"J. Nat. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1895","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fcimb.2017.00318","article-title":"Secretory products of the human GI tract microbiome and their potential impact on Alzheimer\u2019s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus","volume":"7","author":"Zhao","year":"2017","journal-title":"Front. Cell. Infec. Microbiol."},{"key":"10.1016\/j.arr.2021.101451_bib1900","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0169-409X(02)00150-3","article-title":"Vascular disorder in Alzheimer\u2019s disease: role in pathogenesis of dementia and therapeutic targets","volume":"54","author":"Zlokovic","year":"2002","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.arr.2021.101451_bib1905","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","article-title":"Clearing amyloid through the blood\u2013brain barrier","volume":"89","author":"Zlokovic","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101451_bib1910","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2021.101451_bib1915","article-title":"Transport-clearance hypothesis for Alzheimer\u2019s disease and potential therapeutic implications, Madame Curie Bioscience Database [Internet]","author":"Zlokovic","year":"2013","journal-title":"Landes Bioscience."},{"key":"10.1016\/j.arr.2021.101451_bib1920","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1073\/pnas.93.9.4229","article-title":"Glycoprotein 330\/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers","volume":"93","author":"Zlokovic","year":"1996","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.arr.2021.101451_bib1925","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low\u2010density lipoprotein receptor\u2010related protein\u20101: a serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid \u03b2\u2010peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2021.101451_bib1930","first-page":"218","article-title":"Markedly increased platelet membrane fluidity in Down syndrome with a (14q, 21q) translocation","volume":"1","author":"Zubenko","year":"1988","journal-title":"Topics in geriatrics"},{"key":"10.1016\/j.arr.2021.101451_bib1935","article-title":"Platelet membrane fluidity in Alzheimer\u2019s disease and major depression","author":"Zubenko","year":"1987","journal-title":"Am. J. Psychiatry"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721001987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721001987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:51:55Z","timestamp":1761591115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163721001987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":387,"alternative-id":["S1568163721001987"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2021.101451","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: Insights and therapeutic approaches from periphery","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2021.101451","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101451"}}